In gliomas, EMT may significantly affect susceptibility to chemotherapy, as increased ZEB1/ZEB2 and decreased E-cadherin expression levels were observed in TMZ-resistant glioma cells [96]. The gene discussed is CDH1; the disease is central nervous system cancer.